» Authors » Hidemi Furusawa

Hidemi Furusawa

Explore the profile of Hidemi Furusawa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 219
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tanaka T, Tanaka M, Furusawa H, Kamada Y, Sagara Y, Anan K, et al.
Anticancer Res . 2020 Jul; 40(8):4779-4785. PMID: 32727805
Background/aim: Irinotecan is rarely used on the metastatic breast cancer (MBC) setting. S-1 is an oral mixture of tegafur, gimeracil and oteracil. We conducted this pilot study to assess efficacy...
2.
Okita K, Narumi R, Azuma T, Furusawa H, Shidooka J, Takagi S, et al.
J Ther Ultrasound . 2018 Jun; 6:4. PMID: 29951205
Background: The development of imaging technologies and breast cancer screening allowed early detection of breast cancers. High-intensity focused ultrasound (HIFU) is a non-invasive cancer treatment, but the success of HIFU...
3.
Maeda Y, Funagayama M, Shinohara A, Koshimoto C, Furusawa H, Nakahara H, et al.
J Physiol Biochem . 2014 Aug; 70(3):849-55. PMID: 25108556
The influence of human serum albumin (HSA) on the bile acid-mediated inhibition of liver microsomal type 1 11β-hydroxysteroid dehydrogenase (11β-HSD1) was studied in vitro. A rat liver microsomal fraction was...
4.
Yoshimoto M, Takao S, Hirata M, Okamoto Y, Yamashita S, Kawaguchi Y, et al.
Cancer Chemother Pharmacol . 2012 Apr; 70(2):331-8. PMID: 22526409
Purpose: Metronomic combination chemotherapy with the oral fluoropyrimidine doxifluridine/5'-deoxy-5-fluorouridine (5 -DFUR) and oral cyclophosphamide (C) showed promising efficacy in a single-arm study. The oral fluoropyrimidine capecitabine was designed to deliver...
5.
Nakahara H, Yasuda Y, Machida E, Maeda Y, Furusawa H, Komaki K, et al.
Breast Cancer . 2010 Nov; 18(3):152-60. PMID: 21086082
Background: Neoadjuvant chemotherapy (NAC) is commonly utilized to treat operable breast cancer. The purpose of this study was to review the findings of ultrasonography (US) and magnetic resonance (MR) imaging...
6.
Shibuta K, Ueo H, Furusawa H, Komaki K, Rai Y, Sagara Y, et al.
Breast Cancer . 2010 Jun; 18(4):292-8. PMID: 20571962
Background: Estrogen receptor (ER), progesterone receptor (PgR), and HER2 expression status in breast cancer function as prognostic and predictive factors that enable individualized treatment. Intrinsic subtype classification has also been...
7.
Yamaguchi R, Furusawa H, Nakahara H, Inomata M, Namba K, Tanaka M, et al.
Pathol Int . 2007 Dec; 58(1):26-30. PMID: 18067637
Invasive ductal carcinoma (IDC) with central acellular zone is sometimes encountered, but its clinicopathological features have not yet been fully investigated. The clinicopathological features of 10 resected cases of IDC...
8.
Gombos E, Kacher D, Furusawa H, Namba K
Top Magn Reson Imaging . 2007 Apr; 17(3):181-8. PMID: 17414075
This paper will review the experience and current applications of magnetic resonance-guided focused ultrasound surgery (MRgFUS) for treatment of breast tumors. Because of the efficient screening mammography programs, most of...
9.
Furusawa H, Namba K, Nakahara H, Tanaka C, Yasuda Y, Hirabara E, et al.
Breast Cancer . 2007 Jan; 14(1):55-8. PMID: 17244995
MRgFUS (MR guided Focused Ultrasound) being one of the non-surgical ablation techniques. We have already achieved favorable results in the past clinical study of MRgFUS to local treatment. New twenty...
10.
Furusawa H, Namba K, Thomsen S, Akiyama F, Bendet A, Tanaka C, et al.
J Am Coll Surg . 2006 Jun; 203(1):54-63. PMID: 16798487
Background: Magnetic resonance-guided focused ultrasound surgery (MRgFUS) is a noninvasive technique that has been shown to coagulate benign and malignant tumors. The purpose of this study was to evaluate MRgFUS...